BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in BriaCell Therapeutics Corp. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q1 2024
- Shares held
- 391.3K
- −205.1K (−34.4%) vs. Q1 2024
- Total value
- $452.0K
- −$1.36M (−75.0%) vs. Q1 2024
- New holders
- 4
- 4 more added
- Sold out
- 3
- 8 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Redmond Asset Management, LLC | 115,346 | $131.5K | 0.04% | −17,723−13.3% | Reduced |
| Bank of Montreal | 56,341 | $72.1K | 0.00% | −77,900−58.0% | Reduced |
| Onyx Bridge Wealth Group LLC | 50,000 | $57.0K | 0.01% | 00.0% | Unchanged |
| Summit Trail Advisors, LLC | 35,000 | $39.9K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 17,799 | $20.3K | 0.00% | −200−1.1% | Reduced |
| Renaissance Technologies LLC | 15,000 | $17.1K | 0.00% | +2,800+23.0% | Added |
| HighTower Advisors, LLC | 14,728 | $16.0K | 0.00% | +278+1.9% | Added |
| XTX Topco Ltd | 12,364 | $14.1K | 0.00% | +12,364 | New |
| Susquehanna International Group, LLP | 12,357 | $14.1K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 11,558 | $13.2K | 0.00% | +11,558 | New |
| Group One Trading, L.P. | 10,894 | $12.4K | 0.00% | +10,894 | New |
| Concord Wealth Partners | 10,301 | $11.7K | 0.00% | −474−4.4% | Reduced |
| Citadel Advisors LLC | 9,641 | $11.0K | 0.00% | +3,214+50.0% | Added |
| National Bank of Canada | 7,500 | $8.03K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,832 | $4.00K | 0.00% | +232+6.4% | Added |
| TD Waterhouse Canada Inc. | 3,450 | $3.69K | 0.00% | −8,600−71.4% | Reduced |
| Morgan Stanley | 2,658 | $3.03K | 0.00% | −21,006−88.8% | Reduced |
| Advisor Group Holdings, Inc. | 1,026 | $1.17K | 0.00% | −6−0.6% | Reduced |
| HHM Wealth Advisors, LLC | 1,000 | $1.14K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 528 | $602 | 0.00% | −259−32.9% | Reduced |
| K.J. Harrison & Partners Inc | 0 | $0 | 0.00% | −87,044−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −34,222−100.0% | Sold out |
| Rosenberg Matthew Hamilton | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Lynwood Capital Management Inc. | – | – | – | – | Not filed |